An interventional study of "OCFighter" in Obsessive-Compulsive Disorder, sponsored by Hartford Hospital. Completed at 1 site in United States. Open to participants aged 18 Years to 69 Years. Per ClinicalTrials.gov, last updated 2016-01-07.
Sponsored by Hartford Hospital · Not applicable, Interventional, and Treatment
The primary aim of this study is to learn about who is most likely to benefit from guided self-help (GSH) for obsessive-compulsive disorder (OCD).
40 Participants with OCD will be recruited. They will be given access to OC Fighter, an internet OCD treatment program. During the 17 week program, participants will meet with a therapist 9 times. Assessments will occur at pretreatment, post-treatment, 3-month follow up and 6-month follow up.
367 studies on the registry are indexed under Compulsive Personality Disorder; 67 are open to participants now.
This study's enrollment of 26 is below the median of 37 across 306 interventional studies indexed under Compulsive Personality Disorder.
Browse Compulsive Personality Disorder studies →Hartford Hospital is the lead sponsor of 101 studies on the registry; 19 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
OCFighter
Behavioral: "OCFighter"
OCFighter™ s an interactive, internet guided self-help (GSH) treatment program for obsessive-compulsive disorder (OCD). It uses the evidence based approach known as Cognitive Behavioral Therapy (CBT) and was adapted from the previously validated BT STEPS program for OCD. The program teaches the best practice CBT technique to help with OCD called exposure with ritual prevention (ERP).
Also known as: OCFighter, Guided Self-help
Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
The Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions. The total score is reported here and ranges from 0 to 40 with higher scores indicating more severe OCD symptoms.
Time frame: Baseline (pretreatment), 17-weeks (posttreatment), and 6 month-follow-up
Responder Status
Participants who experienced a clinically significant change in Y-BOCS score defined as posttreatment YBOCS score that (a) has decreased by a reliable level (at least 1.96 times the standard deviation of that measure, taking into account the reliability of the measure itself; in this case, a decrease of 5 points or more), and (b) is within the nonclinical range of scores (in this case, a score of 13 or below).
Time frame: Week 17 (post-treatment) and 6-month follow-up
| Milestone | OCFighter Participants |
|---|---|
| Started | 26 |
| Initiated treatment | 24 |
| Completed the posttreatment assessment | 17 |
| Completed 3-month follow-up | 16 |
| Completed 6-month follow-up | 12 |
| Completed | 12 |
| Not completed | 14 |
| Withdrew: Withdrawal by subject | 2 |
| Withdrew: Lost to follow-up | 7 |
| Withdrew: Technical problem | 1 |
| Withdrew: Time constraints | 2 |
| Withdrew: Failed to start treatment | 2 |
The Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions. The total score is reported here and ranges from 0 to 40 with higher scores indicating more severe OCD symptoms.
| units on a scale | OCFighter Participants |
|---|---|
| Baseline (pre-treatment) | 24.67 ± 5.16 |
| week 17 (post-treatment) | 18.29 ± 9.06 |
| 6-month Follow-up | 18.46 ± 7.79 |
Participants who experienced a clinically significant change in Y-BOCS score defined as posttreatment YBOCS score that (a) has decreased by a reliable level (at least 1.96 times the standard deviation of that measure, taking into account the reliability of the measure itself; in this case, a decrease of 5 points or more), and (b) is within the nonclinical range of scores (in this case, a score of 13 or below).
| participants | OCFighter Participants |
|---|---|
| Week 17 (post-treatment) | 5 |
| 6- Month follow-up | 5 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| OCFighter Participants | — | 1/24 (4.2%) | 0/24 (0%) |
| Event | OCFighter Participants |
|---|---|
| Increased DepressionPsychiatric disorders | 1/24 |
| Age, Continuous(years) | OCFighter Participants |
|---|---|
| Mean | 37.08 ± 12.57 |
| Sex: Female, Male(Participants) | OCFighter Participants |
|---|---|
| Female | 17 |
| Male | 9 |
| Region of Enrollment(participants) | OCFighter Participants |
|---|---|
| United States | 26 |
This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Compulsive Personality Disorder→
Hartford Hospital